Table 1.
Enoxaparin and RO-enoxaparin | Tinzaparin and RO-tinzaparin | Dalteparin and RO-dalteparin | |||
---|---|---|---|---|---|
| |||||
Multistep gradient
| |||||
Time (min) | % Eluent B | Time (min) | % Eluent B | Time (min) | % Eluent B |
| |||||
0 | 10 | ||||
0 | 0 | 0 | 5 | 4 | 10 |
5 | 0 | 5 | 5 | 15 | 18 |
130 | 35 | 125 | 35 | 30 | 18 |
140 | 70 | 130 | 70 | 115 | 35 |
145 | 70 | 135 | 70 | 133 | 70 |
148 | 0 | 138 | 5 | 138 | 70 |
170 | 0 | 160 | 5 | 140 | 10 |
160 | 10 | ||||
| |||||
Sample quantity loaded, μg | |||||
| |||||
15 | 15 | 30 | 30 | 30 | 30 |
| |||||
Corresponding Figure
| |||||
| |||||
Fig. 4 and ESM Fig. S5 | ESM Fig. S6 | ESM Fig. S7 |
LC conditions: column C18 100 x 2.1 mm, 2.6 μm; eluents A and B – 10 mM DBA and 10 mM CH3COOH in H2O-CH3CN = 9:1 (v/v) and CH3CN, respectively; flow rate – 0.25 ml/min